PEPG News

Latest breaking news and updates for PEPG stock.

Track all markets on TradingView

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

NEW YORK--(BUSINESS WIRE)---- $PEPG #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. (“PepGen” or the “Company”) (NA...

Are there any early indications of other investors or institutions planning to join the class action, and how could that influence the case's scale? Will the class action lead to increased insider trading activity or changes in insider holdings? How might this development affect PepGen's competitive positioning and relationships with key partners or customers?
Lawsuits
15 days ago
Read more businesswire

Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PepGen To Contact Him Directly To Discuss Their Options If you suffered purchased ...

How might the lawsuit influence institutional investors' sentiment and potential fund re‑allocation? What is the potential impact on PepGen's options market, including implied volatility and open interest? Is there a risk of additional lawsuits or regulatory actions stemming from the current class action?
Lawsuits
17 days ago
Read more prnewswire

PepGen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your Rights - PEPG

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit. CLASS DEFINITION...

What should investors monitor in upcoming SEC filings or company communications regarding this lawsuit? Are there any potential impacts on product approvals, recalls, or regulatory compliance due to the allegations? Will the lawsuit affect PepGen's existing credit facilities, covenants, or ability to raise capital?
Lawsuits
18 days ago
Read more prnewswire

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of...

What are the analyst coverage changes or target price revisions following this earnings release? What is the market’s perception of PepGen's competitive position within the neuromuscular and neurological disease space? How might upcoming FDA or regulatory milestones for the oligonucleotide platform affect short‑term price volatility?
Earnings
19 days ago
Read more businesswire

PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Aug. 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PepGen Inc. ("PepGen" or "the Compa...

How might the lawsuit affect analyst coverage, target price revisions, or institutional ownership of PepGen? What is the likelihood that the case will be settled early versus going to a jury trial? Could the lawsuit result in a leadership or board change at PepGen?
Lawsuits
19 days ago
Read more prnewswire